Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Post by subaru1ion Oct 04, 2023 8:09am
138 Views
Post# 35668483

So now you should be able to answer: How did the FDA get to

So now you should be able to answer: How did the FDA get to Barrie, Ontario.   Here's how they got there.   Having submitted a DMF to the FDA there was no visit needed to go to LABS in Barrie.   When a U.S. pharmaceutical company that has to follow Federal Law, including FDA, referenced the LABS DMF in their drug submission this then made the FDA go to Barrie for the site visit and evaluate the facility.   The FDA approved the Barrie facility which was driven by a U.S. pharmaceutical company calling out the LABS DMF.   

We followed the same type of process in the auto industry in qualifying a new supplier sending out a Supplier Quality Specialist for 3 days onsite visit.  They had to address any short comings before becoming qualified as a supplier.   The purchase order I would issue to a new supplier was only valid if they could pass qualification.   I was a "blended buyer", purchasing and Supplier Quality Specialist and would do the onsite 3 days visit.   

The roadmap and fundamental mechanics are the same.   Now that LABS is FDA approved, they can now ship volume quantities of product as referenced by their DMF to the U.S. pharma company that called out their DMF.   

Be patient, it takes some time for investors to have it sink in and digest it so we are in the digestion period now.   When you see volumes surging into the millions of shares per day, you will know the herd mentality of investors has figured it out.  

Statistically, it's a pretty tight bell curve because all humans have the same type of brain and same intelligence capability.   

So just be patient and let that permeate through out the herd.   They'll come running.  
<< Previous
Bullboard Posts
Next >>